Detalhe da pesquisa
1.
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Blood
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38683966